Compare ICL & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ICL | BRKR |
|---|---|---|
| Founded | 1968 | 1960 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | 7.3B |
| IPO Year | N/A | 2000 |
| Metric | ICL | BRKR |
|---|---|---|
| Price | $5.34 | $48.28 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 13 |
| Target Price | $6.23 | ★ $50.54 |
| AVG Volume (30 Days) | 1.2M | ★ 2.3M |
| Earning Date | 02-25-2026 | 02-12-2026 |
| Dividend Yield | ★ 3.49% | 0.40% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.29 | N/A |
| Revenue | ★ $7,053,000,000.00 | $3,438,900,000.00 |
| Revenue This Year | $5.82 | $3.58 |
| Revenue Next Year | $5.42 | $1.46 |
| P/E Ratio | $19.34 | ★ N/A |
| Revenue Growth | 1.77 | ★ 6.10 |
| 52 Week Low | $4.85 | $28.53 |
| 52 Week High | $7.35 | $63.13 |
| Indicator | ICL | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 44.67 | 48.45 |
| Support Level | $5.38 | $47.84 |
| Resistance Level | $5.58 | $56.22 |
| Average True Range (ATR) | 0.11 | 2.17 |
| MACD | -0.00 | -0.38 |
| Stochastic Oscillator | 4.67 | 16.86 |
ICL Group Ltd is a manufacturer of products based on minerals. The firm is comprised of four segments: phosphate solutions, potash, industrial products, and growing solutions. These segments all contribute to the company's development of agriculture, food, and engineered material products and services. Maximum revenue is generated from its phosphate solutions segment which uses phosphate commodity products, such as phosphate rock and fertilizer-grade phosphoric acid (green phosphoric acid), to produce specialty products. This segment also produces and markets phosphate-based fertilizers. Geographically, the company generates maximum revenue from Brazil followed by, the United States of America, China, United Kingdom, Germany, Spain, Israel, France, India, Netherlands, and other countries.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.